These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Responsibility for drug reactions]. Naess K Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254 [No Abstract] [Full Text] [Related]
43. International aspects of drug monitoring. Role of the World Health Organization. Royall BW WHO Chron; 1971 Oct; 25(10):445-51. PubMed ID: 5131672 [No Abstract] [Full Text] [Related]
44. Health care and institutional pharmacy practice in Japan. Tsubaki T; Iga T; Chandler MH Am J Hosp Pharm; 1994 Feb; 51(4):535-8. PubMed ID: 8017427 [No Abstract] [Full Text] [Related]
45. Surveillance of drug adverse reactions. Campbell JS; Henderson IW Can Med Assoc J; 1972 Jun; 106(12):1285. PubMed ID: 5035130 [No Abstract] [Full Text] [Related]
46. [Control of adverse drug reaction in a hospital environment]. Honorato J; Giráldez J; Mart'i Mass'o R; Fos D; Velasco JL; S'anchez H Rev Med Univ Navarra; 1976; 20():209-11. PubMed ID: 1019512 [No Abstract] [Full Text] [Related]
47. [Reports on drug side effects for the period 1973-1974]. Tidsskr Nor Laegeforen; 1975 Aug; 95(22):1243-7. PubMed ID: 1162667 [No Abstract] [Full Text] [Related]
48. Global challenges for clinical pharmacology in the developing world. Blaschke TF Clin Pharmacol Ther; 2009 Jun; 85(6):579-81. PubMed ID: 19451910 [TBL] [Abstract][Full Text] [Related]
49. The Drug Spotlight Program. Aagaard GN J Assoc Hosp Med Educ; 1978; 1st Quarter():58-60. PubMed ID: 10307276 [No Abstract] [Full Text] [Related]
50. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
51. Drug information center--a rapid source for therapeutic information. Chow MS Conn Med; 1977 Jun; 41(6):375. PubMed ID: 872591 [No Abstract] [Full Text] [Related]
52. [Available list of adverse effects]. Liljestrand A Lakartidningen; 1976 Apr; 73(15):1397. PubMed ID: 1263655 [No Abstract] [Full Text] [Related]
53. Mission, role, and functions of the P & T Committee. Bell JE; Evans PJ; Standish RC Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202 [TBL] [Abstract][Full Text] [Related]
54. [Organization of drug information work in a pharmaceutical information center]. Nikitina NI Farm Zh; 1979; (2):10-2. PubMed ID: 456502 [No Abstract] [Full Text] [Related]
55. Drug information centers: ASHP's role and effect of clinical pharmacy. Walton CA; Knodel LC Am J Hosp Pharm; 1983 Jul; 40(7):1217-8. PubMed ID: 6881164 [TBL] [Abstract][Full Text] [Related]
57. [Pharmacologic surveillance outside the hospital: necessity and methods]. Cuena R; Honorato J; Azanza JR; Suárez JR; Rubio A Rev Med Univ Navarra; 1987; 31(3):163-6. PubMed ID: 3507792 [No Abstract] [Full Text] [Related]
58. [Local reporting of adverse effects--an experimental work at the main hospital]. Hallberg L; Lundborg P Lakartidningen; 1974 May; 71(19):1916-7. PubMed ID: 4133506 [No Abstract] [Full Text] [Related]
59. Experience with a drug information services review committee. Pearson RE; Lauper RD; Davis LJ Am J Hosp Pharm; 1975 Jan; 32(1):31-4. PubMed ID: 1124780 [TBL] [Abstract][Full Text] [Related]
60. Integration of pharmacy into the computerized problem-oriented medical information system (PROMIS)--a demonstration project. Gilroy G; Ellinoy BJ; Nelson GE; Cantrill SV Am J Hosp Pharm; 1977 Feb; 34(2):155-62. PubMed ID: 842545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]